The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients
Abstract
We conducted a prospective, multicenter observational study of adults (n=1447) and children (n=144) with candidemia at tertiary care centers in the United States in parallel with a candidemia treatment trial that included nonneutropenic adults. Candida albicans was the most common bloodstream isolate recovered from adults and children (45% vs. 49%) and was associated with high mortality (47% among adults vs. 29% among children). Three-month survival was better among children than among adults (76% vs. 54%; P<.001). Most children received amphotericin B as initial therapy, whereas most adults received fluconazole. In adults, Candida parapsilosis fungemia was associated with lower mortality than was non-parapsilosis candidemia (24% vs. 46%; P<.001). Mortality was similar among subjects with Candida glabrata or non-glabrata candidemia; mortality was also similar among subjects with C. glabrata candidemia who received fluconazole rather than other antifungal therapy. Subjects in the observational cohort had higher Acute Physiology and Chronic Health Evaluation II scores than did participants in the clinical trial (18.6 vs. 16.1), which suggests that the former subjects are more often excluded from therapeutic trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Self-citationPractice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Self-citation(1999) · American Journal of Infection Control · doi:10.1016/s0196-6553(99)70031-3 · Cited by 901
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679
Blumberg, H. M., Jarvis, W. R., Soucie, J. M., Edwards, J. E., Patterson, J. E., Pfaller, M. A., Rangel‐Frausto, M. S., Rinaldi, M. G., Saiman, L., Wiblin, R. T., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/321811 · Cited by 661
Self-citationTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Self-citationViscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Risk factors for candidemia in Neonatal Intensive Care Unit patients
SAIMAN, L., LUDINGTON, E., PFALLER, M., RANGEL-FRAUSTO, S., WIBLIN, T. R., DAWSON, J., BLUMBERG, H. M., PATTERSON, J. E., RINALDI, M., EDWARDS, J. E., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200004000-00011 · Cited by 587
Self-citationNosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission
Pfaller, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s89 · Cited by 502
Nosocomial Candidemia: Risk Factors and Attributable Mortality
Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1531 · Cited by 502
Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495
Self-citationKao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Komshian, S. V., Uwaydah, A. K., Sobel, J. D., & Crane, L. R. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.379 · Cited by 457
Rangel‐Frausto, M. S., Wiblin, T., Blumberg, H. M., Saiman, L., Patterson, J., Rinaldi, M., Pfaller, M., Edwards, Jr., Jarvis, W., Dawson, J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520194 · Cited by 430
Self-citationWeems, J. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.3.756 · Cited by 399
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378
Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study
Wey, S. B. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100145030 · Cited by 369
KOSSOFF, E. H., BUESCHER, E. S., & KARLOWICZ, M. G. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199806000-00014 · Cited by 330
The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310 · cited 1×
“More recent studies suggest lower overall and attributable mortality rates, which are possibly associated with the earlier recognition of candidemia and the administration of more-aggressive antifungal therapy [17, 18 , 20].”
BackgroundAnaissie, E. J., Darouiche, R. O., Abi-Said, D., Uzun, O., Mera, J., Gentry, L. O., Williams, T., Kontoyiannis, D. P., Karl, C. L., & Bodey, G. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.964 · Cited by 278
Risk factors for nosocomial candidemia: A case-control study in adults without leukemia☆
Bross, J., Talbot, G. H., Greg, M., Shelley, H., & Strom, B. L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90719-5 · Cited by 275
Pfaller, M. A., Jones, R. N., Doern, G. V., Fluit, A. C., Verhoef, J., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., & Hollis, R. J. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00046-2 · Cited by 264
Phillips, P., Shafran, S., Garber, G., Rotstein, C., Smaill, F., Fong, I., Salit, I., Miller, M., Williams, K., Conly, J. M., et al. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01726360 · Cited by 221
Risk factors for candidemia in cancer patients: a case-control study
Karabinis, A., Hill, C., Leclercq, B., Tancrède, C., Baume, D., & Andremont, A. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.3.429-432.1988 · Cited by 210
High rate of non-albicans candidemia in Brazilian tertiary care hospitals
Lopes Colombo, A., Nucci, M., Salomão, R., Branchini, M. L. M., Richtmann, R., Derossi, A., & Wey, S. B. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00042-5 · Cited by 201
Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study
WEESE-MAYER, D. E., FONDRIEST, D. W., BROUILLETTE, R. T., & SHULMAN, S. T. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198702000-00009 · Cited by 197
FRIEDMAN, S., RICHARDSON, S. E., JACOBS, S. E., & OʼBRIEN, K. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200006000-00002 · Cited by 185
Weems, J. J., Chamberland, M. E., Ward, J., Willy, M., Padhye, A. A., & Solomon, S. L. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.6.1029-1032.1987 · Cited by 181
Vertical and Horizontal Transmission of Unique Candida Species to Premature Newborns
Waggoner-Fountain, L. A., Whit Walker, M., Hollis, R. J., Pfaller, M. A., Ferguson, J. E., Wenzel, R. P., & Donowitz, L. G. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.803 · Cited by 172
DATO, V. M., & DAJANI, A. S. (1990) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199005000-00002 · Cited by 161
Candidemia in a Pediatric Population
Stamos, J. K., & Rowley, A. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.571 · Cited by 159
Prophylactic antifungal therapy in the intensive care unit
Weinstein, R. A., Rex, J. H., & Sobel, J. D. (2001) · Clinical Infectious Diseases · doi:10.1086/319763 · Cited by 155
Self-citationRisk Factors for Candidemia in a Children's Hospital
MacDonald, L., Baker, C., & Chenoweth, C. (1998) · Clinical Infectious Diseases · doi:10.1086/514580 · Cited by 141
Ophthalmologic, Visceral, and Cardiac Involvement in Neonates with Candidemia
Noyola, D. E., Fernandez, M., Moylett, E. H., & Baker, C. J. (2001) · Clinical Infectious Diseases · doi:10.1086/319601 · Cited by 137 · cited 1×
“Amphotericin B was the drug of choice administered to the majority of children with candidemia, which reflected a traditional approach for treating a population with frequent complications associated with this disorder, including involvement of the eyes, heart, and CNS [ 51 ].”
BackgroundNosocomial Outbreak of Candida parapsilosis Fungemia Related to Intravenous Infusions
Plouffe, J. F. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630240022010 · Cited by 129
Rowen, J. L., Rench, M. A., Kozinetz, C. A., Adams, J. M., & Baker, C. J. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81375-7 · Cited by 121
Huang, Y., Lin, T., Leu, H. S., Peng, H., Wu, J.-H., & Chang, H. Y. (1999) · Infection · doi:10.1007/bf02560505 · Cited by 111
Trick, W. E., & Fridkin, S. K. (2002) · Cited by 103
Yamamura, D. L. R., Rotstein, C., Nicolle, L. E., & Ioannou, S. (1999) · Europe PMC (PubMed Central) · Cited by 83
Sobel, J. D., Ohmit, S. E., Schuman, P. C., Klein, R. S., Mayer, K. H., Duerr, A. C., Vázquez, J. A., & Rompalo, A. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/317936 · Cited by 83
Cassone, A., Bernardis, F. D., Pontieri, E., Carruba, G., Girmenia, C., Martino, P., Fernandez-Rodriguez, M. L., Quindós, G., & Pontón, J. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.967 · Cited by 72
Wright, W. L., & Wenzel, R. P. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70363-9 · Cited by 70
Risk factors for death among cancer patients with fungemia
Nucci, M., Silveira, M. I., Spector, N., Silveira, F., Velasco, E., Akiti, T., Barreiros, G., Derossi, A., Colombo, A. L., & Pulcheri, W. (1998) · Clinical Infectious Diseases · doi:10.1086/514609 · Cited by 69
Epidemiology of Candidemia - A Nationwide Survey in Israel
Rennert, G., Rennert, H. S., Pitlik, S. D., Finkelstein, R., & Kitzes‐Cohen, R. (2000) · Infection · doi:10.1007/s150100050006 · Cited by 53
Candida infections: outcome and attributable ICU costs in critically ill patients
Pelz, R. K., Lipsett, P. A., Swoboda, S. M., Diener-West, M., Powe, N. R., Brower, R. G., Perl, T. M., Hammond, J. M., & Hendrix, C. W. (2000) · Journal of Intensive Care Medicine · doi:10.1046/j.1525-1489.2000.00255.x · Cited by 45
Goldstein, E. G., Grieco, M. H., Finkel, G. C., & Louria, D. B. (1965) · The Journal of Infectious Diseases · doi:10.1093/infdis/115.3.293 · Cited by 38
Factors influencing experimental candidiasis in mice. I. Alloxan diabetes.
Andriole, V. T., & HASENCLEVER, H. F. (1962) · PubMed Central · Cited by 36
Fichtenbaum, C. J., German, M., Dunagan, W. C., Fraser, V. J., Medoff, G., Diego, J. M., & Powderly, W. G. (1999) · Clinical Infectious Diseases · doi:10.1086/313499 · Cited by 26
Self-citation
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citationEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationPappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Self-citationAntifungal activity of silver nanoparticles against Candida spp.
Panáček, A., Kolář, M., Večeřová, R., Prucek, R., Soukupová, J., Kryštof, V., Hamal, P., Zbořil, R., & Kvítek, L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.065 · Cited by 964
Metadata
- Authors
- Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., Horowitz, H. W., Edwards, J. E., Dismukes, W. E., & NIAID Mycoses Study Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-01
- Volume
- 37
- Issue
- 5
- Pages
- 634-643
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2162221318
- Cited by
- 845
- References
- 54
- FWCI
- 21.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.